Healthy Life Agritec Ltd
Incorporated in 2019, Healthy Life Agritec Limited is in the business of trading milk, live poultry and
fresh meat products[1]
- Market Cap ₹ 48.6 Cr.
- Current Price ₹ 9.80
- High / Low ₹ 46.7 / 8.85
- Stock P/E 23.6
- Book Value ₹ 6.32
- Dividend Yield 0.00 %
- ROCE 8.63 %
- ROE 6.60 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 28.8%
- Company has a low return on equity of 6.17% over last 3 years.
- Promoter holding has decreased over last 3 years: -25.7%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 0.00 | 4.11 | 26.16 | 46.21 | 52.37 | 64.45 | 70.70 | |
| 0.00 | 3.99 | 25.06 | 44.63 | 50.10 | 61.62 | 67.60 | |
| Operating Profit | 0.00 | 0.12 | 1.10 | 1.58 | 2.27 | 2.83 | 3.10 |
| OPM % | 2.92% | 4.20% | 3.42% | 4.33% | 4.39% | 4.38% | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.03 | 0.11 | 0.13 | 0.17 | 0.12 |
| Depreciation | 0.00 | 0.03 | 0.04 | 0.13 | 0.15 | 0.16 | 0.22 |
| Profit before tax | 0.00 | 0.09 | 1.03 | 1.34 | 1.99 | 2.50 | 2.76 |
| Tax % | 22.22% | 26.21% | 28.36% | 25.13% | 25.20% | ||
| 0.00 | 0.07 | 0.76 | 0.97 | 1.49 | 1.87 | 2.06 | |
| EPS in Rs | 0.38 | 0.22 | 0.34 | 0.38 | 0.41 | ||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 35% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 35% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 37% |
| 1 Year: | -73% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 7% |
| 3 Years: | 6% |
| Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 10.01 | 22.01 | 22.01 | 24.81 | 24.81 |
| Reserves | 0.00 | 0.06 | 0.83 | 1.80 | 3.28 | 6.55 | 7.29 |
| 0.00 | 0.00 | 0.85 | 1.26 | 2.52 | 2.69 | 2.66 | |
| 0.00 | 5.64 | 2.95 | 0.88 | 2.13 | 2.30 | 29.94 | |
| Total Liabilities | 0.01 | 5.71 | 14.64 | 25.95 | 29.94 | 36.35 | 64.70 |
| 0.00 | 1.34 | 1.59 | 2.32 | 2.18 | 2.37 | 2.27 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.16 | 3.23 |
| Investments | 0.00 | 0.00 | 9.07 | 9.07 | 9.07 | 9.07 | 9.07 |
| 0.01 | 4.37 | 3.98 | 14.56 | 18.69 | 21.75 | 50.13 | |
| Total Assets | 0.01 | 5.71 | 14.64 | 25.95 | 29.94 | 36.35 | 64.70 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| -0.01 | 1.38 | -1.03 | -11.55 | -6.50 | -0.80 | |
| 0.00 | -1.37 | -9.37 | -0.86 | 0.00 | -3.51 | |
| 0.01 | 0.00 | 10.83 | 12.30 | 1.14 | 4.25 | |
| Net Cash Flow | 0.00 | 0.01 | 0.43 | -0.11 | -5.37 | -0.06 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 293.07 | 26.51 | 58.69 | 100.99 | 88.97 | |
| Inventory Days | 36.97 | 6.63 | 9.66 | 13.49 | 18.80 | |
| Days Payable | 378.27 | 18.53 | 2.87 | 9.17 | 3.12 | |
| Cash Conversion Cycle | -48.23 | 14.61 | 65.48 | 105.31 | 104.65 | |
| Working Capital Days | -111.90 | -3.35 | 98.42 | 102.38 | 99.05 | |
| ROCE % | 225.00% | 18.03% | 7.89% | 8.02% | 8.63% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16h - Newspaper Advertisment regarding Publication of standalone and consolidated Unaudited Financial Results for the quarter ended 31st December,2025 pursuent to regulation 30 and 47 of SEBI(Listing …
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
2d - Care Ratings Q3 (31-Dec-2025) monitoring: Rs24.81 crore rights issue; Rs21.75cr utilised, Rs3.06cr unutilised; no deviations.
- Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015 Held On Today I.E. 14Th February, 2026 2d
-
Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015 Held On Today I.E. 14Th February, 2026
2d - Q3/9M FY26 unaudited results approved; limited review; Rs.2,481.20 lakh rights issue; no fund deviation.
-
Board Meeting Intimation for Approval Of Financial Results For The Quarter Ended 31St December 2025 Pursuant To Regulation 29 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015.
10 Feb - Board meeting on 14 Feb 2026 to approve unaudited Q3 (Dec 31, 2025) results; trading window closed since 1 Jan.
Product Profile:
a) Dairy:[1]
Milk, Milk Powder, Milk Cream, Yogurt, Butter,
Cheese
b) Bakery:[2]
Bread, Buns, Croissant
c) Juices:[3]
Apple, Orange, Mango, Mixed Fruit